Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (901-910 of 933) with videos related to

Pageof 94
Sort By:
The Journal of Pathology|October 15, 2013
Towards the introduction of the 'Immunoscore' in the classification of malignant tumoursJérôme Galon, Bernhard Mlecnik, Gabriela Bindea, et al.
Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.
Breast Cancer Research and Treatment|January 4, 2019
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancerMarius Wunderle, Jutta Pretscher, Sara Y Brucker, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Cancer Research|August 17, 2011
Common breast cancer susceptibility loci are associated with triple-negative breast cancerKristen N Stevens, Celine M Vachon, Adam M Lee, et al.
Cancers|January 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.
Cancers|September 23, 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC StudyBernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon CancerBernhard Mlecnik, Carlo Bifulco, Gabriela Bindea, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Pageof 94

Showing results (901-910 of 933) with videos related to

Sort By:
Pageof 94
The Journal of Pathology|October 15, 2013
Towards the introduction of the 'Immunoscore' in the classification of malignant tumoursJérôme Galon, Bernhard Mlecnik, Gabriela Bindea, et al.
Nature Communications|April 17, 2021
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancerSia Viborg Lindskrog, Frederik Prip, Philippe Lamy, et al.
Breast Cancer Research and Treatment|January 4, 2019
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancerMarius Wunderle, Jutta Pretscher, Sara Y Brucker, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
Gynecologic Oncology|June 7, 2025
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysisZhuxuan Fu, Lauren Borho, Sarah E Taylor, et al.
Cancer Research|August 17, 2011
Common breast cancer susceptibility loci are associated with triple-negative breast cancerKristen N Stevens, Celine M Vachon, Adam M Lee, et al.
Cancers|January 21, 2023
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon CancerBernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, et al.
Cancers|September 23, 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC StudyBernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2020
Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon CancerBernhard Mlecnik, Carlo Bifulco, Gabriela Bindea, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Pageof 94